Cefdinir 300Mg Capsule Suppliers & Bulk Manufacturers
Available Forms: Capsule
Available Strengths: 300mg
Reference Brands: Omnicef (US)
Category:
Antibiotics
Cefdinir Capsule are a broad-spectrum, third-generation cephalosporin antibiotic designed for oral use. They are indicated for the management of bacterial infections including community-acquired pneumonia, acute bronchitis, sinusitis, pharyngitis, tonsillitis, otitis media, and various skin infections. With reliable efficacy and convenient oral administration, Cefdinir Capsuleprovide a trusted option for clinicians treating both common and complex bacterial infections.
Cefdinir 300mg Capsule is available in Capsule
and strengths such as 300mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefdinir 300mg Capsule is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefdinir 300mg Capsule can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing